Live
- Education and Agriculture Sectors Are Top Priorities - MLA Dr. Rajesh Reddy
- Paris Paralympics: PM Modi meets Indian Para-athletes at his residence
- Amazon India creates over 1.1 lakh seasonal job opportunities in India
- No Urea Shortage in Bijinapally Mandal - AO Neethi
- Ganesh Chaturthi 2024: Tradition and Importance of Ganpati Visarjan
- Pitru Paksha 2024: The Significance of Tulsi Puja in Honouring Ancestors
- Harish Rao Condemns Attack on MLA Kaushik Reddy, demands security to MLA
- Rohan Bopanna to play in Tennis Premier League in December
- Never witnessed riots during festivals earlier: Khera slams BJP for K’taka clash
- Four dead after container lorry collides car and motorcycle in Tirupati
Serum working on vaccine for Mpox
New Delhi: Serum Institute of India on Tuesday said it is currently working to develop a vaccine for monkeypox, with positive outcomes expected in a...
New Delhi: Serum Institute of India on Tuesday said it is currently working to develop a vaccine for monkeypox, with positive outcomes expected in a year's time. The World Health Organisation on August 14 declared the Mpox outbreak a public health emergency of international concern.
The move came after a sudden increase in cases was recorded in parts of Africa.
In India, around 30 Mpox cases have been detected since 2022. The most recent case in the country was reported in March 2024.
"In view of the global health emergency declared due to Mpox outbreak, Serum Institute of India is currently working on developing a vaccine for this disease to cater to millions of lives that might be at risk," Serum Institute of India CEO Adar Poonawalla said in a statement.
Hopefully, with the ongoing progress, the Pune-based vaccine major will have more updates and positive news to share within a year's time, he added.
